🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The polyglucosamine, specification L112 is a medical device and in this cli...
Status
Completed
Location
Salztal Klinik GmbH
Start Date
2009-08
Trial ID
NCT02410785
Treatments Being Tested
This trial compares two treatment methods: 1. Orlistat 60 mg to be taken t...
Status
Completed
Location
Diabetological Center
Start Date
2009-11
Trial ID
NCT02529631
Treatments Being Tested
The BEFORE study ((B) EFficacy Of REfigura) is designed to demonstrate the ...
Status
Completed
Location
MIT Gesundheit GmbH
Start Date
2017-04-26
Trial ID
NCT03557424
The polyglucosamine, specification L112, is a medical device and in this cl...
Status
Completed
Location
MAP Center
Start Date
2014-05
Trial ID
NCT02682277
Treatments Being Tested
To test the activity of a polyglucosamine (PG) together with a Standard Man...
Status
Completed
Location
Spoltore - Pescara
Start Date
2017-02-01
Trial ID
NCT03464539
Treatments Being Tested
This research proposes as its main purpose to evaluate the effectiveness of...
Status
Completed
Location
Azienda di Servizi alla Persona
Start Date
2020-05-05
Trial ID
NCT05022732
Treatments Being Tested
The purpose of the study is to evaluate the effect on weight loss in a grou...
Status
Completed
Location
Azienda di Servizi alla Persona Istituzioni Assistenziali Riunite di Pavia
Start Date
2020-04-24
Trial ID
NCT04375696
Treatments Being Tested
Obesity is widespread and the number of overweight people has tripled from ...
Status
Completed
Location
Phase I-Unit, Study Center Bonn (SZB), University Hospital Bonn
Start Date
2021-09-16
Trial ID
NCT05038436
Treatments Being Tested
This clinical investigation is intended to confirm the application of a new...
Status
Not Yet Recruiting
Location
Pisa University Hospital - Clinical Research Unit
Start Date
2025-04-01
Trial ID
NCT06910111
Treatments Being Tested